Articles published by Evolus
Evolus Announces Successful Completion of Phase 2 Study Evaluating “Extra-Strength” Dose of Jeuveau ®
June 22, 2023
From Evolus
Via Business Wire
Tickers
EOLS
Evolus Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
March 08, 2023
From Evolus
Via Business Wire
Tickers
EOLS
Evolus to Participate in the Barclays Global Healthcare Conference
February 28, 2023
From Evolus
Via Business Wire
Tickers
EOLS
Evolus to Report Fourth Quarter and Year End 2022 Results and Provide Business Update
February 22, 2023
From Evolus
Via Business Wire
Tickers
EOLS
Evolus Not Affected by Recent Korean Court Ruling
February 10, 2023
From Evolus
Via Business Wire
Tickers
EOLS
Evolus Receives Regulatory Approval for Nuceiva® in Australia
January 23, 2023
From Evolus
Via Business Wire
Tickers
EOLS
Evolus Extends Term of Credit Facility with Pharmakon Advisors
December 08, 2022
From Evolus
Via Business Wire
Tickers
EOLS
Evolus Reports Third Quarter 2022 Results and Provides Business Update
November 08, 2022
From Evolus
Via Business Wire
Tickers
EOLS
Evolus to Participate in November Conferences
November 02, 2022
From Evolus
Via Business Wire
Tickers
EOLS
Evolus Concludes Certain Royalty Payments; Financial Profile Improves Significantly Starting in the Fourth Quarter of 2022
September 21, 2022
From Evolus
Via Business Wire
Tickers
EOLS
Evolus Announces Inducement Grants for New Chief Financial Officer
September 06, 2022
From Evolus
Via Business Wire
Tickers
EOLS
Evolus Appoints Sandra Beaver as Chief Financial Officer
August 30, 2022
From Evolus
Via Business Wire
Tickers
EOLS
Evolus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
August 29, 2022
From Evolus
Via Business Wire
Tickers
EOLS
Newly Published Post Hoc Analysis Evaluates Efficacy of Jeuveau® in Adult Males Compared to BOTOX®
August 24, 2022
From Evolus
Via Business Wire
Tickers
EOLS
Evolus Launches New Campaign Inspiring Consumers to “Switch Your Tox and Love Evolus Forever”
July 19, 2022
From Evolus
Via Business Wire
Tickers
EOLS
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.